New artificial cell can engulf live bacteria via endocytosis

  30 August 2019

Antibiotic consumption is on the rise, causing increased resistance in bacteria. Antibiotic resistance occurs when bacteria develops the ability to resist the effects of medication that was used to successfully treat it in the past. Without urgent action, the global community is heading for a post-antibiotic era, in which common infections and minor injuries can once again kill. Now, a study from researchers led by the University of Pennsylvania develops artificial cells that can detect and devour bacteria. The team state their artificial phagocytic cells represent an alternative to antibiotics, the mainstream treatment against bacterial infections, and could potentially treat bacteria which have developed antibiotic resistance.

Further reading: Health Innovations
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!